Cargando…

Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma

Multiple RBC transfusions inevitably lead to a state of iron overload before and after high-dose chemotherapy and autologous stem cell transplantation (HDCT/autoSCT). Nonetheless, iron status during post-SCT follow-up remains unknown. Therefore, we investigated post-SCT ferritin levels, factors cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Soo Jin, Kang, Christine, Sung, Ki Woong, Chueh, Hee Won, Son, Meong Hi, Lee, Soo Hyun, Yoo, Keon Hee, Koo, Hong Hoe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314847/ https://www.ncbi.nlm.nih.gov/pubmed/22468098 http://dx.doi.org/10.3346/jkms.2012.27.4.363

Ejemplares similares

Hematologic Recovery after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk Solid Tumors
por: Son, Meong Hi, et al.
Publicado: (2013)

Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma
por: Lee, Na Hee, et al.
Publicado: (2016)

Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
por: Lee, Ji Won, et al.
Publicado: (2017)

Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma: First Report in Korean Population
por: Lim, Hana, et al.
Publicado: (2020)

Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma
por: Choi, Young Bae, et al.
Publicado: (2015)

Infectious Complications during Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Children with High-Risk or Recurrent Solid Tumors
por: Choi, Young Bae, et al.
Publicado: (2016)

MBCL-28. LONG-TERM FOLLOW-UP RESULTS OF REDUCED DOSE CRANIOSPINAL RADIOTHERAPY AND TANDEM HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH HIGH-RISK MEDULLOBLASTOMA
por: Lee, Ji Won, et al.
Publicado: (2020)

Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents
por: Lee, Ji Won, et al.
Publicado: (2017)

Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Atypical Teratoid/Rhabdoid Tumor
por: Sung, Ki Woong, et al.
Publicado: (2016)

High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas
por: Choi, Young Bae, et al.
Publicado: (2016)

Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma
por: Choi, Young Bae, et al.
Publicado: (2019)

Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.
por: Sung, Ki Woong, et al.
Publicado: (2002)

High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients with High-risk Stage 3 Neuroblastoma: 10-Year Experience at a Single Center
por: Suh, Jung Min, et al.
Publicado: (2009)

Etoposide sensitizes neuroblastoma cells expressing caspase 8 to TRAIL
por: Kim, Hye Ryung, et al.
Publicado: (2012)

Efficacy of Tandem High-Dose Chemotherapy and Autologous Stem Cell Rescue in Patients Over 1 Year of Age with Stage 4 Neuroblastoma: The Korean Society of Pediatric Hematology-Oncology Experience Over 6 Years (2000-2005)
por: Sung, Ki Woong, et al.
Publicado: (2010)

Hematopoietic stem cell transplantation in children with acute leukemia: similar outcomes in recipients of umbilical cord blood versus marrow or peripheral blood stem cells from related or unrelated donors
por: Yi, Eun Sang, et al.
Publicado: (2012)

Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma
por: Kim, Chiwoo, et al.
Publicado: (2018)

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
por: Lee, Eunjin, et al.
Publicado: (2020)

Clinical significance of germline telomere length and associated genetic factors in patients with neuroblastoma
por: Bae, Joon Seol, et al.
Publicado: (2022)

Optimal Time to Start Peripheral Blood Stem Cell Collection in Children with High-Risk Solid Tumors
por: Sung, Ki Woong, et al.
Publicado: (2014)

ARID1B alterations identify aggressive tumors in neuroblastoma
por: Lee, Soo Hyun, et al.
Publicado: (2017)

Promising survival rate but high incidence of treatment‐related mortality after reduced‐dose craniospinal radiotherapy and tandem high‐dose chemotherapy in patients with high‐risk medulloblastoma
por: Lee, Ji Won, et al.
Publicado: (2020)

Efficacy of Itraconazole Prophylaxis for Autologous Stem Cell Transplantation in Children with High-Risk Solid Tumors: A Prospective Double-Blind Randomized Study
por: Kim, Yae-Jean, et al.
Publicado: (2011)

Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma
por: Seo, Eun Seop, et al.
Publicado: (2020)

Autologous stem cell transplantation for the treatment of neuroblastoma in Korea.
por: Ryu, Kyung Ha, et al.
Publicado: (2003)

Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma
por: Seo, Eunseop, et al.
Publicado: (2019)

Genome-Wide Association Study for the Identification of Novel Genetic Variants Associated with the Risk of Neuroblastoma in Korean Children
por: Bae, Joon Seol, et al.
Publicado: (2020)

Tandem High-dose Chemotherapy without Craniospinal Irradiation in Treatment of Non-metastatic Malignant Brain Tumors in Very Young Children
por: Ma, Youngeun, et al.
Publicado: (2020)

Human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions
por: Lee, Myoung Woo, et al.
Publicado: (2013)

Neuroblastoma Originating from Extra-abdominal Sites: Association with Favorable Clinical and Biological Features
por: Sung, Ki Woong, et al.
Publicado: (2009)

Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma
por: Lee, Ji Won, et al.
Publicado: (2022)

Gene Expression Profiles of Human Adipose Tissue-Derived Mesenchymal Stem Cells Are Modified by Cell Culture Density
por: Kim, Dae Seong, et al.
Publicado: (2014)

Effect of Ex Vivo Culture Conditions on Immunosuppression by Human Mesenchymal Stem Cells
por: Lee, Myoung Woo, et al.
Publicado: (2013)

Responses and adverse effects of carboplatin-based chemotherapy for pediatric intracranial germ cell tumors
por: Ji, Suntae, et al.
Publicado: (2011)

Neuroblastoma: an ongoing cold front for cancer immunotherapy
por: Kennedy, Paul T, et al.
Publicado: (2023)

Inhibition of N‐myc expression sensitizes human neuroblastoma IMR‐32 cells expressing caspase‐8 to TRAIL
por: Lee, Myoung Woo, et al.
Publicado: (2019)

Erratum: Correction of Title: Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
por: Choi, Young Bae, et al.
Publicado: (2019)

Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
por: Choi, Young Bae, et al.
Publicado: (2019)

International travel of Korean children and Dengue fever: A single institutional analysis
por: Choi, Soo Han, et al.
Publicado: (2010)

Prognostic factors in children with extracranial germ cell tumors treated with cisplatin-based chemotherapy
por: Kim, Jinsup, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_68v4tebg2koohh1pv0f37enmep